Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...

New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Brian Feth and Jonathan Grinstein go behind the headlines to discuss the impact of a Republican administration on Federal ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...

The following is a summary of “Allergic fungal rhinosinusitis linked to other hyper-IgE syndromes through defective TH17 ...

This article explores the process of immune system aging, asking whether there is anything we can do to slow the aging clock ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...